Core Insights - DSS, Inc. reported significant financial improvements in Q1 2025, indicating progress in its financial repositioning strategy and setting a strong foundation for future corporate execution [1][2] Financial Performance - Total revenues increased by 28% year-over-year, driven by a 30% rise in printed product sales and nearly doubling rental income from the real estate segment, which grew from $400,000 to $714,000 [5] - The company completed the sale of its Plano, TX facility for $9.5 million, contributing to $12.88 million in cash from investing activities during the quarter [5] - DSS reduced over $8 million in total debt, demonstrating a commitment to balance sheet optimization [5] - The company raised $1.5 million in new equity capital through its partner company Impact BioMedical during Q1 [5] - Net cash used in operations improved from $2.15 million in Q1 2024 to $1.64 million in Q1 2025, highlighting early operational efficiencies [5] Strategic Focus - The company is focused on streamlining operations and financial discipline, with plans to showcase measurable results from development, operations, and M&A activities as the year progresses [2] - DSS aims to identify high-potential business units and allocate capital effectively to drive long-term value [2]